6-158986384-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_031924.8(RSPH3):​c.242G>A​(p.Arg81Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 1,613,966 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R81W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0071 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 20 hom. )

Consequence

RSPH3
NM_031924.8 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.962

Publications

3 publications found
Variant links:
Genes affected
RSPH3 (HGNC:21054): (radial spoke head 3) The protein encoded by this gene acts as a protein kinase A anchoring protein. Mutations in this gene cause primary ciliary dyskinesia; a disorder characterized by defects of the axoneme in motile cilia and sperm flagella. The homolog of this gene was first identified in the blue-green algae Chlamydomonas as encoding a radial spoke protein that formed a structural component of motile cilia and flagella. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016]
RSPH3 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 32
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Ambry Genetics
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033236146).
BP6
Variant 6-158986384-C-T is Benign according to our data. Variant chr6-158986384-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475836.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0071 (1081/152282) while in subpopulation AFR AF = 0.0193 (801/41556). AF 95% confidence interval is 0.0182. There are 9 homozygotes in GnomAd4. There are 487 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH3NM_031924.8 linkc.242G>A p.Arg81Gln missense_variant Exon 3 of 8 ENST00000367069.7 NP_114130.4 Q86UC2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH3ENST00000367069.7 linkc.242G>A p.Arg81Gln missense_variant Exon 3 of 8 1 NM_031924.8 ENSP00000356036.1 A0A0C4DFU3
RSPH3ENST00000449822.6 linkc.205-3696G>A intron_variant Intron 2 of 5 2 ENSP00000393195.1 A0A0C4DG29

Frequencies

GnomAD3 genomes
AF:
0.00706
AC:
1074
AN:
152164
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00279
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00296
AC:
744
AN:
251362
AF XY:
0.00260
show subpopulations
Gnomad AFR exome
AF:
0.0189
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00290
AC:
4242
AN:
1461684
Hom.:
20
Cov.:
30
AF XY:
0.00273
AC XY:
1987
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0181
AC:
604
AN:
33462
American (AMR)
AF:
0.00170
AC:
76
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000918
AC:
24
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000893
AC:
77
AN:
86250
European-Finnish (FIN)
AF:
0.00109
AC:
58
AN:
53420
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00290
AC:
3226
AN:
1111844
Other (OTH)
AF:
0.00285
AC:
172
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
197
393
590
786
983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00710
AC:
1081
AN:
152282
Hom.:
9
Cov.:
32
AF XY:
0.00654
AC XY:
487
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0193
AC:
801
AN:
41556
American (AMR)
AF:
0.00425
AC:
65
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00279
AC:
190
AN:
68016
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00419
Hom.:
9
Bravo
AF:
0.00761
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.0225
AC:
99
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00375
AC:
455
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00218
EpiControl
AF:
0.00196

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 32 Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 09, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 15, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.1
DANN
Benign
0.29
DEOGEN2
Benign
0.0024
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.62
T;T
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-1.4
.;N
PhyloP100
0.96
PrimateAI
Benign
0.21
T
PROVEAN
Benign
1.2
N;N
REVEL
Benign
0.037
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.030
.;B
Vest4
0.12
MVP
0.055
MPC
0.34
ClinPred
0.000027
T
GERP RS
3.3
Varity_R
0.021
gMVP
0.048
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41267751; hg19: chr6-159407416; API